The Veteran's claim for service connection for primary myelofibrosis was received on February 10, 2011. The Board denied an earlier effective date as the earliest date of claim is February 10, 2011.
The deciding factor: The earliest date of claim is February 10, 2011, when the Veteran submitted a formal or informal claim for service connection for primary myelofibrosis. The Board found that this was the controlling date for the effective date assigned under the factual circumstances in this matter.
- Claimed conditions
- primary myelofibrosis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 100%
- Decision date
- September 7, 2017
- Citation
- 1737507
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1737507.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Veteran's claim for service connection for essential thrombocythemia or primary myelofibrosis was denied as there is no evidence of an earlier effective date due to the PACT Act, and the conditions are not covered by the PACT Act.
- Dismissed
The Veteran's claim for a higher rating for essential thrombocythemia and primary myelofibrosis has been granted with a maximum schedular rating of 100 percent, effective August 10, 2022. The appeal is dismissed as the benefit sought on appeal has already been granted.
- Remanded (sent back)
The Veteran's claims of service connection for primary myelofibrosis, a chronic condition to account for kidney failure, COPD, diabetes, and emphysema are reopened. The issues of service connection for these conditions due to petrochemical exposure, including benzene, are remanded.
- Remanded (sent back)
The Board has found that the VA medical opinion provided in November 2021 did not substantially comply with the remand directives and thus requires another examination to determine if there is at least a 50% chance that the Veteran's myelofibrosis is related to his service, including radiation exposure.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.